{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:16:34Z","timestamp":1783026994268,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI182319-01"],"award-info":[{"award-number":["R01 AI182319-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["AI001336"],"award-info":[{"award-number":["AI001336"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacig.2025.100622","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:53:49Z","timestamp":1764896029000},"page":"100622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High levels of nonblocking anti-interferon and anticytokine autoantibodies in individuals with mRNA vaccine\u2013induced systemic allergic reactions"],"prefix":"10.1016","volume":"5","author":[{"given":"Muge","family":"Kalaycioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaurya","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad B.","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Frischmeyer-Guerrerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100622_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 Vaccine - United States, December 21, 2020\u2013January 10, 2021","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacig.2025.100622_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US - December 14, 2020\u2013January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2025.100622_bib3","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2025.100622_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2025.100622_bib5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2024.10.019","article-title":"COVID-19 mRNA vaccine allergy","volume":"155","author":"Csuth","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100622_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.anai.2022.05.013","article-title":"A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies","volume":"129","author":"Corey","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2025.100622_bib7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2024.03.001","article-title":"A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination","volume":"153","author":"Khalid","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100622_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacig.2022.10.003","article-title":"The conundrum of COVID-19 mRNA vaccine\u2013induced anaphylaxis","volume":"2","author":"Khalid","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jacig.2025.100622_bib9","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.jaip.2021.06.035","article-title":"Vaccine hesitancy: drivers and how the allergy community can help","volume":"9","author":"Turner","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100622_bib10","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.vaccine.2021.04.066","article-title":"Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines","volume":"39","author":"Somiya","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2025.100622_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.it.2008.12.004","article-title":"Linking allergy to autoimmune disease","volume":"30","author":"Valenta","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jacig.2025.100622_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180012","article-title":"Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity","volume":"134","author":"Bodansky","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacig.2025.100622_bib12","author":"Yin"},{"key":"10.1016\/j.jacig.2025.100622_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163150","article-title":"Autoantibodies are highly prevalent in non\u2013SARS-CoV-2 respiratory infections and critical illness","volume":"8","author":"Feng","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacig.2025.100622_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jacig.2025.100622_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000345365","article-title":"Interferon-\u03bbs: special immunomodulatory agents and potential therapeutic targets","volume":"5","author":"Zheng","year":"2013","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jacig.2025.100622_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2567.2008.02862.x","article-title":"Interferon-\u03bb1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro","volume":"125","author":"Srinivas","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jacig.2025.100622_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.gene.6364382","article-title":"Human interferon lambda-1 (IFN-lambda1\/IL-29) modulates the Th1\/Th2 response","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.jacig.2025.100622_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.intimp.2014.04.022","article-title":"Adenovirus expressing IFN-lambda1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma","volume":"21","author":"Li","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jacig.2025.100622_bib20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1365-2222.2008.03045.x","article-title":"Type III IFN-\u03bb mRNA expression in sputum of adult and school-aged asthmatics","volume":"38","author":"Bullens","year":"2008","journal-title":"Clin Exp Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:17:23Z","timestamp":1783023443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325002231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2772829325002231"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100622","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High levels of nonblocking anti-interferon and anticytokine autoantibodies in individuals with mRNA vaccine\u2013induced systemic allergic reactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100622"}}